Almost half (47%) of patients with cancer do not think that they have been sufficiently involved in the treatment decision process. This is what the international All.Can cancer initiative reveals in its report Patient insights [more]
Almost 95 billion dollars of lost earnings. That’s the estimated price USA paid in 2015 for cancer-related deaths in people aged 16 to 84 years, according to a paper recently published in JAMA Oncology by [more]
Cancer patient advocates from 26 European countries, active across a wide spectrum of cancer types, spent four days last week at the first training course to be developed and run by advocates themselves.The intensive training ‘Academy’ was organised by WECAN [more]
Seminal data from decades ago already demonstrated a marked underrepresentation of older patients in clinical trials: now an analysis of more than 300 randomised clinical trials (RCTs) shows not only that the disparity persists but the gap between trial and population median ages is widening. [more]
Among patients with a history of cancer, risk of Alzheimer disease (AD) might be lower: a study published in JAMA Network Open showed that elderly cancer patients had modestly higher memory function and slower memory [more]
The scientific community should always be on the same page as the patients, and in order to really meet the needs of adolescents and young adults (AYA) a smart and flexible digital system is somehow [more]
Several new agents and combination therapies for the treatments of haematological malignant and non-malignant diseases were presented at the 24th congress of the European Haematology Association (EHA) that took place 13-16 June 2019 in Amsterdam [more]
It seems that the big revolution linked to the introduction of checkpoint inhibitor drugs is still far to come. According to estimates recently published in JAMA Network Open, only a small percentage of patients eligible [more]
Between 2018 and 2040, patients requiring first course chemotherapy will significantly increase annually, accordingly to a modelling study published in The Lancet Oncology. For the first time researchers estimated the scale of chemotherapy provision at regional, [more]
The mCODE project will provide a common platform and language to collect all the data on cancer patients. The initial set of standards has been released at ASCO 2019 in Chiacgo Data collection, retrival and [more]
Data from 20 European countries show that in the past 15 years colorectal cancer (CRC) incidence increased among young adults. The awareness of the changing epidemiology of CRC could have a practical implication: to reconsider [more]
A group of members of the European Parliament is promoting a manifesto “to improve services for patients in an area of still high unmet need and reduce the societal impact of breast cancer by elevating [more]
Randomized controlled trials that have been used for the FDA approval of new anticancer drugs were sometimes based on a flawed design, with suboptimal control arms: “Using a suboptimal control arm may bias a trial in [more]